Maine Enacts Dual Laws Tightening Health Care Deal Reviews
Maine passed two laws ramping up regulatory scrutiny of health care mergers and acquisitions.
Why it matters: Tighter reporting and review rules will require in-house counsel and deal lawyers to adjust deal planning and diligence, especially where private equity is involved or Maine revenue is significant. Legal and compliance teams must now manage longer timelines, higher regulatory risk, and ongoing monitoring for qualifying deals.
- Chapter 661 mandates premerger federal antitrust (HSR Act) filings to Maine’s AG, effective July 14, 2026.
- Filings apply to health care deals involving entities with Maine headquarters, operations, or ≥20% Maine revenue.
- Non-compliant parties face up to $10,000 in daily civil penalties for missing filings.
- Chapter 690, effective January 1, 2027, requires 180-day advance notice to DHHS for ‘material change transactions’ by private equity, hedge funds, or MSOs.
- Transactions are subject to review, with possible post-deal monitoring at 1, 2, and 5 years after closing.
Maine's legislature passed two landmark laws—Chapter 661 (H.P. 1481) and Chapter 690 (H.P. 1480)—dramatically expanding oversight of health care industry mergers and acquisitions.
- Chapter 661 (effective July 14, 2026) requires health care entities with a strong Maine nexus (headquarters, business operations, or over 20% of total revenue generated in state) to file copies of their federal premerger notification (per the HSR Act) with the Maine Attorney General. The HSR Act, or Hart-Scott-Rodino Act, is a federal antitrust law requiring advance notice for large transactions above a set threshold.
- Failure to file can trigger civil penalties of up to $10,000 per day.
- Chapter 690 (effective Jan. 1, 2027) covers 'material change transactions'—defined as deals where private equity, hedge funds, or management services organizations acquire control or significant assets from a provider. It requires at least 180 days' advance notice to Maine’s Department of Health and Human Services (DHHS), including detailed disclosures and potentially a state cost and market impact review.
- After deal approval, DHHS will monitor qualifying transactions at one, two, and five-year intervals to ensure ongoing compliance and assess impact on health care cost, quality, and access.
"These laws signal Maine’s intent to exercise oversight over private equity and similar investment activity in its health care sector," noted attorney Deborah A. Daccord, partner at Mintz Levin, in a recent client alert. Similar measures, like Massachusetts' HCMO process, are gaining traction as states aim to maximize public value from health care consolidation.
For legal teams, adapting to these requirements means developing early-state compliance workflows, tracking evolving definitions (like the annual HSR threshold, $119.5M for 2024), and monitoring new multi-agency review triggers that may delay or alter deal strategies.
By the numbers:
- $10,000 per day — maximum daily civil penalty for failing to file HSR notice with Maine AG
- 180 days — required advance notice before closing certain health care transactions with private equity involvement
- $119.5M — federal 2024 HSR Act threshold for reporting large deals, referenced in state criteria
Yes, but: Stand-alone physician practices and certain low-revenue entities may fall outside the law’s reporting requirements, limiting impact for smaller-scale deals.
What's next: Health care providers, private equity, and legal teams should review their deal pipelines for transactions extending beyond July 2026 or January 2027 to ensure compliance with new Maine laws.